|
|
Volumn 8, Issue 2, 2015, Pages 253-255
|
|
Chasing-and Catching-the Wild Goose: Hypothesis-Free Post-Hoc Stratification Studies as a New Paradigm for Drug Development
|
|
Author keywords
biomarkers; clinical trial; drug approval; Editorials; genome wide association study; pharmacogenetics
|
|
Indexed keywords
BIOLOGICAL MARKER;
CHOLESTEROL ESTER TRANSFER PROTEIN;
DALCETRAPIB;
ADENYLATE CYCLASE;
THIOL DERIVATIVE;
COST EFFECTIVENESS ANALYSIS;
DRUG DEVELOPMENT;
GENOME ANALYSIS;
HEALTH CARE POLICY;
HUMAN;
MEDICAL LITERATURE;
PHASE 3 CLINICAL TRIAL (TOPIC);
POST HOC ANALYSIS;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RETROSPECTIVE STUDY;
REVIEW;
STRATIFIED SAMPLE;
ATHEROSCLEROSIS;
CHROMOSOME 16;
FEMALE;
GENE LINKAGE DISEQUILIBRIUM;
GENETIC POLYMORPHISM;
GENETICS;
MALE;
PHARMACOGENETICS;
ADENYLYL CYCLASES;
ATHEROSCLEROSIS;
CHROMOSOMES, HUMAN, PAIR 16;
FEMALE;
HUMANS;
LINKAGE DISEQUILIBRIUM;
MALE;
PHARMACOGENETICS;
POLYMORPHISM, GENETIC;
SULFHYDRYL COMPOUNDS;
|
|
EID: 84942941507
PISSN: 1942325X
EISSN: 19423268
Source Type: Journal
DOI: 10.1161/CIRCGENETICS.115.001037 Document Type: Review |
|
Times cited : (7)
|
|
References (7)
|
